- Product Name Boc-HPh-Leu-Phe-OMe
- cas 868539-96-2
- purity 99%
Manufacturer supply Boc-HPh-Leu-Phe-OMe 868539-96-2 with sufficient stock and high standard
- Molecular Formula: C31H43N3O6
- Molecular Weight: 553.699
- Boiling Point: 753.4±60.0 °C(Predicted)
- PKA: 11.22±0.46(Predicted)
- PSA: 122.83000
- Density: 1.123±0.06 g/cm3(Predicted)
- LogP: 5.11660
868539-96-2 Relevant articles
Preparation and biological evaluation of soluble tetrapeptide epoxyketone proteasome inhibitors
Lei, Meng,Zhang, Haoyang,Miao, Hang,Du, Xiao,Zhou, Hui,Wang, Jia,Wang, Xueyuan,Feng, Huayun,Shi, Jingmiao,Liu, Zhaogang,Shen, Jian,Zhu, Yongqiang
, p. 4151 - 4162 (2019/08/07)
A series of novel tetrapeptidyl epoxyket...
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome
Xie, Stanley C.,Gillett, David L.,Spillman, Natalie J.,Tsu, Christopher,Luth, Madeline R.,Ottilie, Sabine,Duffy, Sandra,Gould, Alexandra E.,Hales, Paul,Seager, Benjamin A.,Charron, Carlie L.,Bruzzese, Frank,Yang, Xiaofeng,Zhao, Xiansi,Huang, Shih-Chung,Hutton, Craig A.,Burrows, Jeremy N.,Winzeler, Elizabeth A.,Avery, Vicky M.,Dick, Lawrence R.,Tilley, Leann
, p. 10053 - 10066 (2018/11/23)
The Plasmodium proteasome represents a p...
PROCESS FOR THE PREPARATION OF (2S)-N-((S)-1-((S)-4-METHYL-1-((R)-2-METHYL OXIRAN-2-YL)-1-OXOPENTAN-2-YLCARBAMOYL)-2-PHENYLETHYL)-2-((S)-2-(2-MORPHOLINO ACETAMIDO)-4-PHENYLBUTANAMIDO)-4-METHYLPENTANAMIDE
-
, (2016/11/14)
The present invention relates to process...
CRYSTALLINE PEPTIDE EPOXY KETONE PROTEASE INHIBITORS AND THE SYNTHESIS OF AMINO ACID KETO-EPOXIDES
-
Paragraph 0447-0450, (2016/10/27)
The invention relates to crystalline pep...
868539-96-2 Process route
-
-
82732-07-8,108524-68-1,142926-43-0,100564-78-1
Boc-L-homophenylalanine
-
-
Leu-Phe-OMe trifluoroacetate
-
-
868539-96-2
(S)-methyl 2-((S)-2-tert.butoxycarbonyIamino-4-phenylbutanamido-4-methylpentanamido)-3-phenylpropanoate
| Conditions | Yield |
|---|---|
|
With
(benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine;
In
DMF (N,N-dimethyl-formamide);
at 0 - 20 ℃;
|
|
|
With
benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine;
In
dichloromethane;
at 0 - 20 ℃;
for 12h;
|
-
-
15136-32-0,87976-66-7,120342-25-8,5874-73-7
(N-(tert-butoxycarbonyl)-L-leucinyl)-L-phenylalanine methyl ester
-
-
82732-07-8,108524-68-1,142926-43-0,100564-78-1
Boc-L-homophenylalanine
-
-
868539-96-2
(S)-methyl 2-((S)-2-tert.butoxycarbonyIamino-4-phenylbutanamido-4-methylpentanamido)-3-phenylpropanoate
| Conditions | Yield |
|---|---|
|
(N-(tert-butoxycarbonyl)-L-leucinyl)-L-phenylalanine methyl ester;
With
trifluoroacetic acid;
In
dichloromethane;
at 0 - 20 ℃;
for 2h;
Boc-L-homophenylalanine;
With
(benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine;
In
dichloromethane; N,N-dimethyl-formamide;
at 0 - 20 ℃;
Inert atmosphere;
|
21.59 g
|
|
(N-(tert-butoxycarbonyl)-L-leucinyl)-L-phenylalanine methyl ester;
With
trifluoroacetic acid;
In
dichloromethane;
Boc-L-homophenylalanine;
With
benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine;
In
dichloromethane;
|
246 mg
|
868539-96-2 Upstream products
-
82732-07-8
Boc-L-homophenylalanine
-
13734-34-4
N -tert -butoxycarbonyl-L -phenylalanine
-
38155-18-9
L-leucyl-L-phenylalanine methyl ester
-
13139-15-6
N -tert -butoxycarbonyl-L -leucine
868539-96-2 Downstream products
-
868539-99-5
C2 HF3 O2 *C26 H35 N3 O4
-
868540-08-3
C28 H36 ClN3 O5
-
1140908-89-9
C32 H44 N4 O6
-
868540-16-3
(S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenyipropanoic acid